Novavax Reports Second Quarter 2024 Financial Results and Operational Highlights
Go back to Novavax Reports Second Quarter 2024 Financial Results and Operational Highlights| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 8.82 +0.40 (4.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.42 | 52 Week High | $9.23 | |||
| Open | $8.44 | 52 Week Low | $1.16 | |||
| Day High | $9.20 | P/E | N/A | |||
| Day Low | $8.44 | EPS | $-0.30 | |||
| Volume | 6,895,225 | |||||

